UMIN-CTR Clinical Trial

Basic information
Public title	Study on improvement of coldness by ingestion of black ginger supplement
Acronym	Improvement of coldness by black ginger supplement
Scientific Title	Study on improvement of coldness by ingestion of black ginger supplement
Scientific Title:Acronym	Study on improvement of coldness by ingestion of black ginger supplement
Region	Japan

Condition
Condition	coldness
Classification by specialty	Endocrinology and Metabolism
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To investigate the effects of ingestion of black ginger supplement on improvement of coldness
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	coldness
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Cross-over
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Treatment
Type of intervention	Food
Interventions/Control_1	The subjects ingested the placebo meal,and ingested the active meal after 7days.
Interventions/Control_2	The subjects ingested the active meal,and ingested the placebo meal after 7days.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	80 years-old >
Gender	Male and Female
Key inclusion criteria	1) Healthy male and female between 20 and 80 years old 2) Individuals who has subjective symptoms of coldness 3) Individuals who can refrain from over drinking and over eating during the test period 4) Individuals who understand the purpose and contents of the experiment
Key exclusion criteria	1)Subjects who are contracting or treating severe diabetes and kidney and/or liver diseases 2)Individuals who have a chronic diseases and regularly use drugs 3)Pregnant women, or women with intending to become pregnant, and lactating woman 4)Individuals participating or intending to participate in a drug administration test 5)Individuals judged by the doctor to be unsuitable
Target sample size	20

Research contact person
Name of lead principal investigator	1st name Kazunari Middle name Last name Tanaka
Organization	Univercity of Nagasaki
Division name	Faculty of Nursing and Nutrition
Zip code	8512195
Address	1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL	0958135216
Email	katanaka@sun.ac.jp

Public contact
Name of contact person	1st name Hideki Middle name Last name Ito
Organization	Univercity of Nagasaki
Division name	Regional Collaboration Center
Zip code	8512195
Address	1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
TEL	0958135216
Homepage URL
Email	katanaka@sun.ac.jp

Sponsor
Institute	Univercity of Nagasaki
Institute
Department

Funding Source
Organization	charle Co., Ltd.
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Univercity of Nagasaki
Address	1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
Tel	0958135216
Email	katanaka@sun.ac.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2020 Year 02 Month 08 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled	20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2020 Year 01 Month 11 Day
Date of IRB	2019 Year 12 Month 16 Day
Anticipated trial start date	2020 Year 01 Month 11 Day
Last follow-up date	2020 Year 02 Month 16 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2020 Year 01 Month 30 Day
Last modified on	2020 Year 02 Month 26 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044827